Trial Profile
A 3-Month, Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy of Levodopa/Carbidopa/Entacapone vs. Levodopa/Carbidopa in Parkinson's Disease Patients With Impairment of Activities of Daily Living and Early Wearing Off With Levodopa
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2015
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa/entacapone (Primary) ; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms DERBI
- Sponsors Novartis
- 18 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2009 Results have been presented at EFNS 2009.
- 06 Jun 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.